Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2021

MissionIRNewsBreaks – Brain Scientific Inc.’s (BRSF) E-Tattoo Will Be ‘Next Wave of Innovation for Neurology’

Posted on February 22, 2021 by MissionIR

Brain Scientific (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. As scientists work to understand what causes Parkinson’s, Alzheimer’s, dementia and other neurological issues, BRSF is making inroads in helping … Continue reading →

Posted in Brain Scientific Inc. BRSF | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Eyes Transformation as Berubicin Becomes Subject of Active Clinical Trials

Posted on February 22, 2021 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. The company’s pipeline includes Berubicin for the treatment of patients with glioblastoma multiforme … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Hollywall Entertainment Inc.’s (HWAL) HW Vision to Advance Technological Footprint Through Strategic Agreement

Posted on February 22, 2021 by MissionIR

Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, has begun the rollout of its new wholly owned subsidiary HW Vision. According to a recent update, the subsidiary will provide branded cellular equipment and services, streaming media content, live … Continue reading →

Posted in Hollywall Entertainment Inc. HWAL | Leave a comment

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Posted on February 22, 2021 by MissionIR

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in Europe XPhyto’s Covid-ID Lab system is designed to help industries … Continue reading →

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment

PowerTap, an Investee Company of Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Announces USA Hydrogen Station Distribution Model

Posted on February 22, 2021 by MissionIR

PowerTap Hydrogen Fueling has signed a definitive agreement with the Andretti Group to create an optimized network by leveraging the latter’s operational expertise and global reach PowerTap plans to have 500 operational hydrogen filling stations deployed across the country by … Continue reading →

Posted in Clean Power Capital Corp. MOTNF | Leave a comment

MissionIRNewsBreaks – Amesite (NASDAQ: AMST) Founder, CEO Slated to Present at Upcoming Diamond Equity Research Emerging Growth Conference

Posted on February 22, 2021 by MissionIR

Amesite(NASDAQ: AMST) founder and CEO Dr. Ann Marie Sastry is scheduled to present at the Diamond Equity Research Emerging Growth Invitational. The one-day premier event will be held on Wednesday, Feb. 24, with Sastry’s presentation scheduled for 12:20 p.m. ET. During her … Continue reading →

Posted in Amesite Inc. AMST, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report

Posted on February 22, 2021 by MissionIR

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a research report by Encode Ideas L.P., a health care focused research … Continue reading →

Posted in Processa Pharmaceuticals Inc. PCSA | Leave a comment

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation Alternatives to Current Standard of Care for Anxiety Disorders

Posted on February 22, 2021 by MissionIR

American Psychiatric Association poll reveals 62% of respondents have anxiety about COVID-19 Recent FDA Drug Safety Communication requires updated Boxed Warning for benzodiazepines commonly used to treat anxiety disorders VTGN is committed to developing and commercializing PH94B, a first-in-class pherine … Continue reading →

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – Clean Power Capital Corp.’s (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) PowerTap to Commercialize 3rd Generation Blue Hydrogen System into New Verticals

Posted on February 22, 2021 by MissionIR

Clean Power (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) today provided additional information about how the onsite hydrogen production and dispensing technology being developed by PowerTap Hydrogen Fueling Corp., an investee company of Clean Power, will be used in other commercial … Continue reading →

Posted in Clean Power Capital Corp. MOTNF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Expedited Formation of Team to Launch Test System, Also Comments on Lawsuit Against German Subsidiary

Posted on February 22, 2021 by MissionIR

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) announced that it has accelerated the creation of a commercial team formed to launch its point-of-care COVID-19 RT-PCR (“RT-PCR”) test system, called the COVID ID Lab. The lab was developed by XPhyto’s exclusive … Continue reading →

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment